← Back to Search

Other

Optimal BP Treatment Thresholds for Postpartum High Blood Pressure

Phase 4

Recruiting

Led By Alisse K Hauspurg, MD

Research Sponsored by Alisse Hauspurg

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Postpartum individuals ≥18 years old

Preeclampsia or gestational hypertension diagnosis (complying ACOG criteria)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up enrollment through six months postpartum

Awards & highlights

Study Summary

This trial will assess whether tight BP control in postpartum people with HDP can reduce BP & hospital readmissions. Up to 60 people will be studied at Magee-Women's Hospital.

Who is the study for?

This trial is for postpartum individuals over 18 who were diagnosed with preeclampsia or gestational hypertension. Participants must be enrolled in a remote blood pressure management program.Check my eligibility

What is being tested?

The study is testing whether tight control of blood pressure after giving birth (using specific medication thresholds) leads to better outcomes than usual care, including lower BP at six months and fewer hospital readmissions.See study design

What are the potential side effects?

Potential side effects are not explicitly listed, but may include those commonly associated with blood pressure medications such as dizziness, headache, fatigue, or changes in kidney function.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of participants eligible, enrolled and retained (feasibility)

Secondary outcome measures

Anti-hypertensive medication use

Anti-hypertensive medication use (efficacy)

Change in MAP

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (Tight Blood Pressure Control) GroupExperimental Treatment1 Intervention

BP medication will be started if a subject's hospital BP consistently exceeds 140/90 mmHg or her home BP consistently exceeds 135/85 mmHg.

Group II: Usual Care GroupActive Control1 Intervention

Standard of care BP medication will usually be started if a subject's BP consistently exceeds 150/100 mmHg at any point.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Alisse HauspurgLead Sponsor

2 Previous Clinical Trials

170 Total Patients Enrolled

Alisse K Hauspurg, MDPrincipal InvestigatorUPMC Magee Women's Hospital

1 Previous Clinical Trials

60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the window of enrollment still open for participants in this research?

"This investigation, initially launched on November 15th 2023, is actively looking for participants according to records hosted on clinicaltrials.gov. It was last edited 5 days later on the twentieth of November."

Answered by AI

Does this clinical research include participants aged 85 and above?

"The minimum age of participants for this study is 18 and the maximum age that will be considered is 55, as outlined in the criteria."

Answered by AI

Does my profile fit the criteria for participating in this clinical investigation?

"Aiming to enrol 60 participants, this trial is looking for postpartum individuals aged 18 and 55 that have been diagnosed with preeclampsia or gestational hypertension according to American College of Obstetricians and Gynecologists criteria. These patients must also be enrolled in a remote blood pressure management program."

Answered by AI

What is the cap for enrollees in this clinical trial?

"Yes, as is evidenced by the details posted on clinicaltrials.gov, this medical trial is seeking participants. It was first made available to the public in November 15th 2023 and most recently updated on 11/20/2023. The team behind it aims to recruit 60 individuals from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimal Blood Pressure Treatment Thresholds Postpartum

Alisse Hauspurg 2023. "Optimal Blood Pressure Treatment Thresholds Postpartum". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06069102.

All > Womens Health